Hims & Hers Health, Inc. (NYSE: HIMS) Stock Competitors & Peer Comparison

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, SIRO has a market cap of 22B. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while SIRO trades at $109.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas SIRO's P/E ratio is 31.88. In terms of profitability, HIMS's ROE is -0.02%, compared to SIRO's ROE of +0.14%. Regarding short-term risk, HIMS is more volatile compared to SIRO. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check SIRO's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, MMED has a market cap of 5.5B. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while MMED trades at $19.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas MMED's P/E ratio is -25.29. In terms of profitability, HIMS's ROE is -0.02%, compared to MMED's ROE of -0.14%. Regarding short-term risk, HIMS is less volatile compared to MMED. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check MMED's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, OMCL has a market cap of 1.7B. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while OMCL trades at $36.81.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas OMCL's P/E ratio is 19.27. In terms of profitability, HIMS's ROE is -0.02%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, HIMS is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check OMCL's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, DRTS has a market cap of 1.2B. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while DRTS trades at $13.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas DRTS's P/E ratio is -19.61. In terms of profitability, HIMS's ROE is -0.02%, compared to DRTS's ROE of -0.73%. Regarding short-term risk, HIMS is more volatile compared to DRTS. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check DRTS's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, MLAB has a market cap of 574.4M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while MLAB trades at $102.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas MLAB's P/E ratio is 10.36. In terms of profitability, HIMS's ROE is -0.02%, compared to MLAB's ROE of +0.04%. Regarding short-term risk, HIMS is more volatile compared to MLAB. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check MLAB's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, LAB has a market cap of 313.2M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while LAB trades at $0.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas LAB's P/E ratio is -11.43. In terms of profitability, HIMS's ROE is -0.02%, compared to LAB's ROE of -0.18%. Regarding short-term risk, HIMS is more volatile compared to LAB. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check LAB's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, STXS has a market cap of 139M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while STXS trades at $1.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas STXS's P/E ratio is -8.35. In terms of profitability, HIMS's ROE is -0.02%, compared to STXS's ROE of -1.53%. Regarding short-term risk, HIMS is less volatile compared to STXS. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check STXS's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, FONR has a market cap of 117.8M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while FONR trades at $19.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas FONR's P/E ratio is 19.09. In terms of profitability, HIMS's ROE is -0.02%, compared to FONR's ROE of +0.04%. Regarding short-term risk, HIMS is more volatile compared to FONR. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check FONR's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, LNSR has a market cap of 74.2M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while LNSR trades at $6.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas LNSR's P/E ratio is 6.16. In terms of profitability, HIMS's ROE is -0.02%, compared to LNSR's ROE of -5.15%. Regarding short-term risk, HIMS is less volatile compared to LNSR. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check LNSR's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, KDLY has a market cap of 68.1M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while KDLY trades at $11.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas KDLY's P/E ratio is -15.48. In terms of profitability, HIMS's ROE is -0.02%, compared to KDLY's ROE of -0.85%. Regarding short-term risk, HIMS is more volatile compared to KDLY. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check KDLY's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, NEUE has a market cap of 60.9M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while NEUE trades at $6.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas NEUE's P/E ratio is -0.38. In terms of profitability, HIMS's ROE is -0.02%, compared to NEUE's ROE of +0.05%. Regarding short-term risk, HIMS is more volatile compared to NEUE. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check NEUE's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, SNWV has a market cap of 50.6M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while SNWV trades at $5.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas SNWV's P/E ratio is 17.82. In terms of profitability, HIMS's ROE is -0.02%, compared to SNWV's ROE of +17.28%. Regarding short-term risk, HIMS is less volatile compared to SNWV. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check SNWV's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, EKSO has a market cap of 38.6M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while EKSO trades at $15.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas EKSO's P/E ratio is -3.11. In terms of profitability, HIMS's ROE is -0.02%, compared to EKSO's ROE of -1.77%. Regarding short-term risk, HIMS is less volatile compared to EKSO. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check EKSO's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, BEAT has a market cap of 29.1M. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while BEAT trades at $0.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas BEAT's P/E ratio is -0.94. In terms of profitability, HIMS's ROE is -0.02%, compared to BEAT's ROE of -10.34%. Regarding short-term risk, HIMS is less volatile compared to BEAT. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check BEAT's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, STSSW has a market cap of 839.4K. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while STSSW trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas STSSW's P/E ratio is -0.03. In terms of profitability, HIMS's ROE is -0.02%, compared to STSSW's ROE of N/A. Regarding short-term risk, HIMS is more volatile compared to STSSW. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check STSSW's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, SPAN has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while SPAN trades at $29.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas SPAN's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.02%, compared to SPAN's ROE of +0.17%. Regarding short-term risk, HIMS is less volatile compared to SPAN. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check SPAN's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, EXAC has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while EXAC trades at $49.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas EXAC's P/E ratio is 3510.33. In terms of profitability, HIMS's ROE is -0.02%, compared to EXAC's ROE of +0.00%. Regarding short-term risk, HIMS is more volatile compared to EXAC. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check EXAC's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, ABCO has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while ABCO trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas ABCO's P/E ratio is 0.52. In terms of profitability, HIMS's ROE is -0.02%, compared to ABCO's ROE of +0.19%. Regarding short-term risk, HIMS is more volatile compared to ABCO. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check ABCO's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, SCAI has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while SCAI trades at $55.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas SCAI's P/E ratio is 63.45. In terms of profitability, HIMS's ROE is -0.02%, compared to SCAI's ROE of +0.09%. Regarding short-term risk, HIMS is more volatile compared to SCAI. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check SCAI's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, LDR has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while LDR trades at $67.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas LDR's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.02%, compared to LDR's ROE of +1.17%. Regarding short-term risk, HIMS is more volatile compared to LDR. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check LDR's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, MZOR has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while MZOR trades at $58.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas MZOR's P/E ratio is -70.18. In terms of profitability, HIMS's ROE is -0.02%, compared to MZOR's ROE of -0.14%. Regarding short-term risk, HIMS is more volatile compared to MZOR. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check MZOR's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, MEDC has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while MEDC trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas MEDC's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.02%, compared to MEDC's ROE of N/A. Regarding short-term risk, HIMS is less volatile compared to MEDC. This indicates lower risk in terms of short-term price fluctuations for HIMS.Check MEDC's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, STJ has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while STJ trades at $80.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas STJ's P/E ratio is 34.69. In terms of profitability, HIMS's ROE is -0.02%, compared to STJ's ROE of +0.21%. Regarding short-term risk, HIMS is more volatile compared to STJ. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check STJ's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, LPNT has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while LPNT trades at $64.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas LPNT's P/E ratio is 67.44. In terms of profitability, HIMS's ROE is -0.02%, compared to LPNT's ROE of +0.05%. Regarding short-term risk, HIMS is more volatile compared to LPNT. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check LPNT's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, CYNO has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while CYNO trades at $66.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas CYNO's P/E ratio is 105.35. In terms of profitability, HIMS's ROE is -0.02%, compared to CYNO's ROE of +0.03%. Regarding short-term risk, HIMS is more volatile compared to CYNO. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check CYNO's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, PMC has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while PMC trades at $29.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas PMC's P/E ratio is 47.95. In terms of profitability, HIMS's ROE is -0.02%, compared to PMC's ROE of +0.04%. Regarding short-term risk, HIMS is more volatile compared to PMC. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check PMC's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, ABAX has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while ABAX trades at $83.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas ABAX's P/E ratio is 70.62. In terms of profitability, HIMS's ROE is -0.02%, compared to ABAX's ROE of +0.10%. Regarding short-term risk, HIMS is more volatile compared to ABAX. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check ABAX's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, EVHC has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while EVHC trades at $45.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas EVHC's P/E ratio is -3.20. In terms of profitability, HIMS's ROE is -0.02%, compared to EVHC's ROE of +0.07%. Regarding short-term risk, HIMS is more volatile compared to EVHC. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check EVHC's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, COTV has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while COTV trades at $44.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas COTV's P/E ratio is 26.51. In terms of profitability, HIMS's ROE is -0.02%, compared to COTV's ROE of +0.14%. Regarding short-term risk, HIMS is more volatile compared to COTV. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check COTV's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, AMSG has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while AMSG trades at $67.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas AMSG's P/E ratio is N/A. In terms of profitability, HIMS's ROE is -0.02%, compared to AMSG's ROE of +0.08%. Regarding short-term risk, HIMS is more volatile compared to AMSG. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check AMSG's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, SPNC has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while SPNC trades at $38.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas SPNC's P/E ratio is -24.03. In terms of profitability, HIMS's ROE is -0.02%, compared to SPNC's ROE of -0.61%. Regarding short-term risk, HIMS is more volatile compared to SPNC. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check SPNC's competition here

Hims & Hers Health, Inc. (NYSE: HIMS) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HIMS stands at 7B. In comparison, DSCI has a market cap of 0. Regarding current trading prices, HIMS is priced at $31.59 on the NYSE, while DSCI trades at $7.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HIMS currently has a P/E ratio of -315.90, whereas DSCI's P/E ratio is -0.02. In terms of profitability, HIMS's ROE is -0.02%, compared to DSCI's ROE of -0.00%. Regarding short-term risk, HIMS is more volatile compared to DSCI. This indicates higher risk in terms of short-term price fluctuations for HIMS.Check DSCI's competition here